Your session is about to expire
← Back to Search
Prenatal Supplements for Male Infertility
Study Summary
This trial studies a male fertility supplement to see if it improves sperm quality in men with infertility.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You don't have a diagnosed condition called varicocele, which affects the veins in the testicles.You are not able to have children.You are currently taking any antioxidant supplements, except for a basic multivitamin, within the past three months.
- Group 1: Power Prenatal for Sperm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals of legal age being accepted for this clinical investigation?
"As mandated by the trial's inclusion criteria, applicants must be between 18 and 45 years old."
Who meets the eligibility criteria for participation in this clinical experiment?
"To qualify for this study, applicants must suffer from male infertility and be in the 18-45 year old age bracket. The team is currently accepting up to 50 participants."
Are there any openings for this research project at the moment?
"As of today, this trial is actively recruiting participants. Initially posted on April 1st 2022 and recently updated August 20th 2023, the study requires volunteers to participate."
How many participants are being monitored for this experiment?
"Affirmative. According to the clinicaltrials.gov webpage, this study was initially posted on April 1st 2022 and is still actively seeking patients as of August 20th 2021. This trial targets 50 participants from a single medical centre."
Share this study with friends
Copy Link
Messenger